Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer

scientific article published on September 2003

Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.JU.0000079761.56154.E5
P698PubMed publication ID12913756

P2093author name stringJames L Mohler
O Harris Ford
Kris E Gaston
Desok Kim
Swaroop Singh
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)990-993
P577publication date2003-09-01
P1433published inJournal of UrologyQ15709979
P1476titleRacial differences in androgen receptor protein expression in men with clinically localized prostate cancer
P478volume170

Reverse relations

cites work (P2860)
Q33561073A role for the androgen-receptor in clinically localized and advanced prostate cancer
Q90429876African-American Prostate Normal and Cancer Cells for Health Disparities Research
Q37408547Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men.
Q41465042Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
Q33775730Androgen receptor mutations and polymorphisms in African American prostate cancer.
Q34425907Androgen receptor signaling and mutations in prostate cancer
Q42261015Androgen receptor-target genes in african american prostate cancer disparities
Q34544617BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer
Q35431040Black men have lower rates than white men of biochemical failure with primary androgen-deprivation therapy.
Q40420426Chemoprevention in African American Men With Prostate Cancer
Q92181417Comparative analysis of p16 expression among African American and European American prostate cancer patients
Q34035973Copy number and gene expression differences between African American and Caucasian American prostate cancer
Q37702713Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians
Q34872970Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer
Q35745791Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?
Q50792392Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
Q38820582Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer
Q37056110Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
Q57433696Environmentally Induced Alterations in the Epigenome Affecting Obesity and Cancer in Minority Populations
Q30248216Epidemiology of Prostate and Testicular Cancer
Q33970160Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.
Q38442842Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue.
Q36758880Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes
Q34205227Evidence for molecular differences in prostate cancer between African American and Caucasian men
Q37343525Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity
Q91267187Factors influencing prostate cancer treatment decisions for African American and white men
Q37139054Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
Q57286596Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells
Q34432522Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer
Q33526534Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
Q84406110Impact of race on biochemical disease recurrence after prostate brachytherapy
Q35144499Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale
Q24810351Java Web Start based software for automated quantitative nuclear analysis of prostate cancer and benign prostate hyperplasia
Q38734374MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
Q27008271MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans
Q38265565Mini-review: androgen receptor phosphorylation in prostate cancer
Q33633160Minireview: the molecular and genomic basis for prostate cancer health disparities
Q41334556Molecular basis for prostate cancer racial disparities.
Q45327318Molecular mechanisms involving prostate cancer racial disparity
Q37418937Molecular mechanisms involving prostate cancer racial disparity.
Q41564129Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
Q38056217Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison
Q38905604Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling.
Q44726749Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.
Q34284547Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research
Q38683379Prostate cancer in men of African origin.
Q37763709Prostate cancer screening 2010: updated recommendations from the American Cancer Society
Q47576479Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer
Q34542337Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups
Q38557382Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database
Q42631882Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database
Q55360389Racial disparities and considerations for active surveillance of prostate cancer.
Q37592047Racial disparities in prostate cancer: a molecular perspective
Q92211919Racial disparities, cancer and response to oxidative stress
Q37616008Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation
Q37629551Stromal Androgen Receptor in Prostate Cancer Development and Progression
Q39386421TMPRSS2-ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-analysis of Racial Differences
Q55279811Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.
Q33807569The Impact of Tobacco Use on Outcomes and Toxicity in a Predominantly Minority Population of Males with Prostate Cancer Receiving External Beam Radiation
Q42562784The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study
Q37384116The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis
Q79878142[Morbidity in Subsaharian immigrants in a urban area]

Search more.